Published in J Exp Med on July 01, 1977
Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med (1980) 3.13
Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates. Infect Immun (1982) 1.56
Analysis of the response of B cells from CBA/N-defective mice to nonspecific T cell help. J Exp Med (1981) 0.85
Alteration of clonal profile. III. T15 ontogenetic advantages are not sufficient for establishing idiotypic dominance in adoptive transfer. J Exp Med (1981) 0.82
B-cell subsets responsive to fluorescein-conjugated antigens. III. Differential effect of E. Coli lipopolysaccharide on T-dependent and T-independent responses in vivo. Immunology (1979) 0.81
Mitogenic activity of water-soluble adjuvant obtained from Bacterionema matruchotii. Infect Immun (1980) 0.77
IR gene regulation of the response to trinitrophenyl-polysaccharides. Two independent genes are required for antibody production. J Exp Med (1983) 0.77
Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93
Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med (1969) 18.89
Plaque forming cells: methodology and theory. Transplant Rev (1974) 3.92
An in vitro primary immune response to 2,4,6-trinitrophenyl substituted erythrocytes: response against carrier and hapten. J Immunol (1970) 3.63
Induction of antibody-forming cell clones in microcultures. Eur J Immunol (1972) 2.98
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Stimulation of a T-independent primary anti-hapten response in vitro by TNP-lipopolysaccharide (TNP-LPS). J Immunol (1975) 2.30
Cellular requirements for the primary in vitro antibody response to DNP-ficoll. J Exp Med (1974) 2.10
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
B Cell heterogeneity - difference in the size of B lymphocytes responding to T dependent and T independent antigens. Cell Immunol (1975) 1.78
Antibody response to phosphorylcholine in vitro. II. Analysis of T-dependent and T-independent responses. Eur J Immunol (1976) 1.63
Murine B-cell subpopulations responsive to T-dependent and T-independent antigens. J Exp Med (1976) 1.49
Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen. J Immunol (1976) 1.19
The failure to show a necessary role for C3 in the in vitro antibody response. Eur J Immunol (1975) 1.08
Polyclonal stimulation of lymphocytes by macrophages. Eur J Immunol (1976) 0.94
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
Isolation of monoclonal antibodies specific for products of avian oncogene myb. Mol Cell Biol (1984) 2.50
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses (1994) 2.47
Which gp160 vaccine? Nature (1993) 2.27
Antigen recognition and the immune response. Humoral and cellular immune responses to small mono- and bifunctional antigen molecules. J Exp Med (1972) 1.86
Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex. J Virol (2000) 1.85
The oxidation state of iron at high pressure. Science (1969) 1.85
Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J Virol (1994) 1.72
Purification of functional, determinant-specific, idiotype-bearing murine T cells. J Exp Med (1978) 1.70
The functional dissection of an antigen molecule: specificity of humoral and cellular immune responses to glucagon. J Exp Med (1971) 1.62
Antigen recognition and the immune response: the capacity of L-tyrosine-azobenzenearsonate to serve as a carrier for a macromolecular hapten. J Immunol (1971) 1.57
Murine B-cell subpopulations responsive to T-dependent and T-independent antigens. J Exp Med (1976) 1.49
Antibodies to the scrapie protein decorate prion rods. J Immunol (1985) 1.46
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion. J Virol (2001) 1.45
Studies on the relation of a prior immune response to immunogenicity. Immunology (1967) 1.37
Immunochemical specificity: recent conceptual advances. Immunochemistry (1969) 1.31
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol (2006) 1.29
Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells. J Immunol (1993) 1.26
The capacity of bifunctional antigens to bridge antibody molecules and to mediate cell cooperation. Immunochemistry (1975) 1.23
The complexity of structures involved in T-cell activation. Annu Rev Immunol (1983) 1.22
The chemical nature of macrophage RNA-antigen complexes and their relevance to immune induction. J Exp Med (1969) 1.16
Phage-neutralizing activity in light polypeptide chains of rabbit antibody. Immunochemistry (1965) 1.16
Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4. Protein Sci (1996) 1.14
Antigen-specific molecules from murine T lymphocytes and T cell hybridomas. Mol Immunol (1980) 1.13
Immunochemical studies on the poly-gamma-D-glutamyl capsule of Bacillus anthracis. I. Characterization of the polypeptide and of the specificity of its reaction with rabbit antisera. Biochemistry (1966) 1.13
Recent advances with recombinant bacterial vaccine vectors. Mol Med Today (2000) 1.11
Idiotype profile of an immune response. I. Contrasts in idiotypic dominance between primary and secondary responses and between IgM and IgG plaque-forming cells. J Exp Med (1981) 1.10
Spleen weight as a measure of marrow cell growth in irradiated mice. Proc Soc Exp Biol Med (1965) 1.05
Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway. Infect Immun (1999) 1.04
Idiotype connectance in the immune system. I. Expression of a cross-reactive idiotype on induced anti-p-azophenylarsonate antibodies and on endogenous antibodies not specific for arsonate. J Exp Med (1983) 1.03
Qualitative and quantitative determination of mixtures of amino acids using 2,4,6-trinitrobenzenesulfonic acid. Anal Biochem (1967) 1.03
Tolerance induction by an apparently non-immunogenic molecule. Nature (1970) 1.02
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling. J Exp Med (1998) 1.01
Antigen recognition and the immune response. "Self-help" with symmetrical bifunctional antigen molecules. J Exp Med (1972) 1.00
Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. J Clin Invest (1993) 0.98
Immunogenicity of glucagon: determinants responsible for antibody binding and lymphocyte stimulation. Science (1971) 0.97
Influence of thymus cells on erythropoiesis of parental marrow in irradiated hybrid mice. Proc Soc Exp Biol Med (1968) 0.95
Binding of a polypeptide antigen to ribonucleic acid from macrophage, HeLa and Escherichia coli cells. J Immunol (1971) 0.95
Spatial requirements between haptenic and carrier determinants for T-dependent antibody responses. J Exp Med (1978) 0.94
Immunochemical studies on the poly-gamma-D-glutamyl capsule of Bacillus anthracis. 3. The activity with rabbit antisera of peptides derived from the homologous polypeptide. Biochemistry (1968) 0.93
Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product. Proc Natl Acad Sci U S A (1985) 0.93
Graft-vs.-Host activity of thymocytes: relationship to the role of thymocytes in hemopoiesis. Blood (1972) 0.93
An aggregating immunoglobulin in hyperimmune equine anti-pneumococcal sera. J Immunol (1968) 0.92
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody. AIDS Res Hum Retroviruses (1993) 0.92
Production of a fibronectin-associated lymphokine by cloned mouse T cells. J Immunol (1988) 0.92
Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine (1995) 0.91
Rosette formation between murine lymphocytes and erythrocytes. A new locus in the H-2 region. J Exp Med (1979) 0.90
Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles. J Virol (2008) 0.90
Arsonate-specific murine T cell clones. I. Genetic control and antigen specificity. J Exp Med (1983) 0.90
The anatomy of an antigen molecule: functional subregions of L-tyrosine-p-azobenzenearsonate. Mol Immunol (1984) 0.90
Interleukin 3 promotes erythroid burst formation in "serum-free" cultures without detectable erythropoietin. Proc Natl Acad Sci U S A (1985) 0.90
Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1 alpha and MIP-1 beta secretion without inducing TNF-alpha and IL-1 beta. J Hum Virol (1999) 0.90
When is speckle noise multiplicative? Appl Opt (1982) 0.89
Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling. Proc Natl Acad Sci U S A (1999) 0.89
Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine (2001) 0.88
Complement-dependent and -independent pathways of T cell-B cell cooperation. J Immunol (1977) 0.88
Communications. N-terminal residues of heavy chains of human IgA myeloma proteins. J Immunol (1969) 0.88
Antigen specific T cell hybrids--II. T cell hybrids which bind azobenzenearsonate. Mol Immunol (1980) 0.87
Immunogenicity of biotinylated hapten-avidin complexes. Mol Immunol (1984) 0.86
Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. Vaccine (2003) 0.86
Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1. FEMS Immunol Med Microbiol (2003) 0.86
Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. J Biotechnol (1996) 0.86
In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160. AIDS Res Hum Retroviruses (1996) 0.86
A hemolytic plaque assay for activated murine T cells. J Exp Med (1979) 0.85
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta. Proc Natl Acad Sci U S A (2001) 0.85
Activation of B cell subsets by T-dependent and T-independent antigens. Adv Exp Med Biol (1978) 0.85
Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Res Hum Retroviruses (1997) 0.85
Pyrrolidonecarboxylic acid at the N-terminal positions of polypeptide chains from leopard shark immunoglobulins. J Immunol (1970) 0.84
The effect of pressure on the oxidation state of iron, ii. Oxygen ligands. Proc Natl Acad Sci U S A (1968) 0.84
Immunochemical studies on the poly-gamma-D-glutamyl capsule of Bacillus anthracis. V. The in vivo fate and distribution in rabbits of the polypeptide in immunogenic and nonimmunogenic forms. Isr J Med Sci (1969) 0.84
Analysis and measurement of the modal-noise probability distribution for a step-index optical fiber. Opt Lett (1980) 0.84
A mathematical analysis of the DCT coefficient distributions for images. IEEE Trans Image Process (2000) 0.83
Immunochemical studies on the poly-gamma-D-glutamyl capsule of Bacillus anthracis. II. The synthesis of eight dipeptides and four tripeptides of glutamic acid. Biochemistry (1966) 0.83
Improved measurement of calcium mobilization by flow cytometry. Biotechniques (1997) 0.82
Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine. Vaccine (1995) 0.82
Laser-induced local heating of multilayers. Appl Opt (1982) 0.82
A polypeptide chain from leopard shark 19S immunoglobulin analogous to mammalian J chain. J Immunol (1971) 0.81
Cellular interaction between thymocytes and transplanted marrow stem cells. Transplant Proc (1971) 0.81
Components of fraction 3 and pepsin-digested fraction 3 from papain-digested rabbit gamma-globulin. Immunochemistry (1965) 0.80
On the role of thymus in hemopoietic differentiation. Blood Cells (1978) 0.80
Choroid plexus carcinoma presenting as an intraparenchymal mass. J Neurosurg (2001) 0.80
An amplifier cell in hemopoiesis. Exp Hematol (1978) 0.79
Further studies on the relationship of the thymus to hemopoiesis. Transplantation (1972) 0.79
Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine. Dev Biol Stand (1994) 0.79
Cell size distribution in the thymus as a function of age. J Cell Physiol (1972) 0.79